Stanford, CA3 Active Studies

Peripheral T-Cell Lymphoma Clinical Trials in Stanford, CA

Find 3 actively recruiting peripheral t-cell lymphoma clinical trials in Stanford, CA. Connect with local research sites and explore new treatment options.

3
Active Trials
3
Sponsors
2,072
Enrolling

Recruiting Peripheral T-Cell Lymphoma Studies in Stanford

About Peripheral T-Cell Lymphoma Clinical Trials in Stanford

Peripheral T-cell lymphomas are a diverse group of aggressive non-Hodgkin lymphomas that develop from mature T-cells. They account for about 10-15% of all NHL cases. Treatment includes combination chemotherapy, stem cell transplant, and newer targeted agents.

There are currently 3 peripheral t-cell lymphoma clinical trials recruiting participants in Stanford, CA. These studies are seeking a combined 2,072 participants. Research is being sponsored by Associazione Angela Serra per la ricerca sul cancro, Memorial Sloan Kettering Cancer Center, Kyowa Kirin, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.

Peripheral T-Cell Lymphoma Clinical Trials in Stanford — FAQ

Are there peripheral t-cell lymphoma clinical trials in Stanford?

Yes, there are 3 peripheral t-cell lymphoma clinical trials currently recruiting in Stanford, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Stanford?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Stanford research site will contact you about next steps.

Are clinical trials in Stanford free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Stanford studies also compensate for your time and travel.

What peripheral t-cell lymphoma treatments are being tested?

The 3 active trials in Stanford are testing new therapies including novel drugs, biologics, and treatment approaches for peripheral t-cell lymphoma.

Data updated October 15, 2026 from ClinicalTrials.gov